Welcome to Tasly Institute of Life Rejuvenation in Tianjin, where we're transforming disease-oriented medication into personalized healthcare through revolutionary cell therapies, using Mesenchymal Stromal Cells as the key modulator for organismal rejuvenation.
Our Mission & Vision
Transformative Vision
Revolutionize healthcare through personalized cell therapies
Innovative Science
Develop novel strategies using MSCs as powerful biological modulators
Core Mission
Bridge cutting-edge science with real-world regenerative healthcare solutions
The Science: Mesenchymal Stromal Cells (MSCs)
Multipotent Potential
MSCs possess remarkable self-renewal capabilities and can differentiate into various cell types, making them ideal candidates for regenerative medicine applications.
Immunomodulation
These powerful cells regulate immune responses, reducing inflammation and promoting healing through their unique secretory profile.
Clinical Recognition
The FDA milestone approval of MSCs for steroid-refractory GvHD validates their therapeutic potential in advanced cellular therapies.
Novel Strategies & Innovative Platforms
AI-Driven Modeling
Leveraging artificial intelligence to predict therapeutic outcomes and optimize cell therapies
Genetic Engineering
Modifying MSCs to enhance therapeutic potential for targeted applications
EV Therapies
Developing extracellular vesicle treatments for cell-free therapeutic options
Biomarker Integration
Smart integration of disease biomarkers for precision medicine approaches
Clinical Impact & Human Applications
Cardiovascular Therapies
Regenerating heart tissue after injury
Autoimmune Treatments
Regulating immune responses in chronic conditions
Pediatric GvHD
First FDA-approved MSC therapy
Why Cell-Based Rejuvenation?
Paradigm Shift
Moving from symptom management to whole-organism health optimization
Broad Applications
Potential to address 920+ conditions in worldwide clinical trials
Personalization
Therapies tailored to individual biomarkers and immune profiles
Meet Our 36 Young Genius Minds
Brilliant Scientists
All under age 40, pushing boundaries of cellular rejuvenation
Patents Filed
Groundbreaking intellectual property in cell therapy
Publications
Research featured in world-leading scientific journals
Awards
International recognition for pioneering contributions
Team Spotlight: Leaders in Innovation
Dr. Xin Jin
Chief Cellular Biologist specializing in MSC differentiation pathways. Harvard Medical School graduate with pioneering work in exosome therapeutics.
Dr. Jin Lai
Head of AI & Bioinformatics. MIT PhD developing predictive models for cell therapy outcomes using advanced machine learning algorithms.
Dr. Yaya Zhang
Lead Geneticist revolutionizing CRISPR applications in MSC engineering. Princeton graduate with 12 patents in cell modification techniques.
Collaborations & Global Partnerships
Academic Medical Centers
Partnerships with leading universities and teaching hospitals for clinical validation and translation
International Networks
Clinical trial consortiums across Asia, Europe, and North America accelerating therapy approvals
Training Initiatives
Fellowship programs developing the next generation of cell therapy specialists
Join Us: Contact & Opportunities
Postdoctoral Fellow
PhD in Cell Biology, Genetics or related field
Ongoing
Research Scientist
MSc/PhD with bioinformatics experience
June 30, 2023
Clinical Research Associate
Medical background with research experience
July 15, 2023
Tasly Institute welcomes collaboration with biotech and pharmaceutical companies. We offer technology licensing, joint research programs, and clinical trial partnerships.
Email: partnerships@taslyinstitute.cn
Phone: +86 22 8319 XXXX
Address: Tasly Life Science Innovation Park, Xiqing District, Tianjin, 300380, China
Pioneering Cell-Based Rejuvenation for Personalized Healthcare